Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$1.48B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.46B
Operating Margin
0.00%
TTM Avg
17.19%
3Y Avg
8.60%
5Y Avg
8.60%
Market Cap
$1.48B
Operating Margin
13.07%
TTM Avg
10.79%
3Y Avg
8.54%
5Y Avg
8.59%
Market Cap
$1.44B
Operating Margin
-73.77%
TTM Avg
-87.58%
3Y Avg
-121.21%
5Y Avg
-119.21%
Market Cap
$1.44B
Operating Margin
7.03%
TTM Avg
2.87%
3Y Avg
2.90%
5Y Avg
2.58%
Market Cap
$1.51B
Operating Margin
0.09%
TTM Avg
-3.29%
3Y Avg
-12.30%
5Y Avg
-11595.24%
Market Cap
$1.43B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GH Research PLC (GHRS) | $1.47B | 0.00% | 0.00% | 0.00% | 0.00% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.48B | 0.00% | 0.00% | 0.00% | 0.00% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | 0.00% | 17.19% | 8.60% | 8.60% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | 13.07% | 10.79% | 8.54% | 8.59% |
| Certara, Inc. (CERT)vs › | $1.46B | 1.86% | 2.28% | 0.69% | -0.42% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -73.77% | -87.58% | -121.21% | -119.21% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 7.03% | 2.87% | 2.90% | 2.58% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 0.09% | -3.29% | -12.30% | -11595.24% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutex Health, Inc. (NUTX)vs › | $1.52B | 31.49% | 29.35% | -34.88% | -5.38% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
